| Literature DB >> 28615689 |
Zhonglong Liu1, Tianguo Dai1,2, Zhonghe Wang3, Zhiyuan Zhang1, Weiliu Qiu1, Yue He4.
Abstract
Osteoradionecrosis of the mandible (ORNM) is one of the most dreaded complications of radiotherapy. The poor healing capacity of soft tissue after radiation may lead to surgical failure. The current study was designed to identify prognostic factors for postoperative infection (PPI) and propose corresponding prophylaxis and intervention protocols. A retrospective study was conducted concerning ORNM patients from 2000 to 2015. A risk-stratification score and nomogram model were established to predict the risk of PPI. A total of 257 patients were analyzed, and the total incidence of PPI was 23.3% (60/257). In multiple logistic regression analysis, radiation dose [Formula: see text]80 Gy (versus <80 Gy, OR = 2.044, P = 0.035, 95% CI: 1.05-3.979), bilateral ORNM (versus unilateral, OR = 4.120, P = 0.006, 95% CI: 1.501-11.307), skin fistula (versus none, OR = 3.078, P = 0.040, 95% CI: 1.05-9.023), and implant utilization (versus none, OR = 2.115, P = 0.020, 95% CI: 1.125-3.976) were significantly associated with PPI. The susceptibility to PPI in patients with risk-stratification scores of 14-22 was 2.833 times that of patients with scores of 7-13, and 7.585 times that of cases defined as scores of 0-6. The discrimination capability of the nomogram model was estimated using a ROC curve with an AUC of 0.708, revealing potentially useful predictive abilities. In conclusion, current risk-stratification scores and nomogram models effectively predicted the risk of PPI in ORNM patients.Entities:
Mesh:
Year: 2017 PMID: 28615689 PMCID: PMC5471205 DOI: 10.1038/s41598-017-03672-2
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Flow diagram of patients selection.
Baseline characteristics of ORNM patients.
| No. of Patient (N%) | |
|---|---|
| Age (Yr) | |
| <60 | 170 (66.1) |
| | 87 (33.9) |
| Gender | |
| Male | 202 (78.6) |
| Female | 55 (21.4) |
| Smoking | |
| None | 174 (67.7) |
| Yes | 83 (32.3) |
| Alcohol consumption | |
| None | 198 (77.0) |
| Yes | 59 (23.0) |
| Systemic disease | |
| None | 199 (77.4) |
| Yes | 58 (22.6) |
Primary tumor before radiation.
| Primary location | No. of cases | % |
|---|---|---|
| Nasopharyngeal | 96 | 37.4 |
| Tongue | 49 | 19.1 |
| Buccal | 18 | 7.0 |
| Mouth floor | 17 | 6.6 |
| Gingiva | 16 | 6.2 |
| Oropharyngeal | 13 | 5.1 |
| Jaw | 9 | 3.5 |
| Tonsil | 8 | 3.1 |
| Palate | 7 | 2.7 |
| Parotid gland | 7 | 2.7 |
| Submandibular gland | 7 | 2.7 |
| Neck | 6 | 2.3 |
| Others | 4 | 1.6 |
Figure 2(A) Radiation dose distribution among 257 patients with 73 cases received dosage 80 Gy; (B) Distribution of patients among varied time interval between radiotherapy complete and the onset of ORNM.
Figure 3Distribution of lesion sites of ORNM.
Figure 4Clinical manifestations of ORNM and their distribution among patients.
Therapeutic methods and implant utilization.
| Methods | Total (%) |
|---|---|
| Curettage/Sequestrectomy | 29 (11.3) |
| Extensive resection only | 72 (28.0) |
| Resection with reconstruction | |
| Fibular flap | 63 (24.5) |
| PMMF | 71 (27.6) |
| ALT | 11 (4.3) |
| DCIA | 4 (1.6) |
| Latissimus dorsi flap | 4 (1.6) |
| Others | 3 (1.2) |
| Implant utilization | |
| None | 151 (58.8) |
| Yes | 106 (41.2) |
*PMMF: pectoralis major myocutaneous flap; *ALT: anterolateral thigh flap; *DCIA: deep circumflex iliac arteryperforator flap.
Postoperative infection and corresponding treatments.
| Type | No. of cases (total = 60) | Treatments |
|---|---|---|
| Swelling and pyometra | 15 (25%) | Conservative method in 15 cases |
| Tissue split with infection | 13 (21.7%) | Conservative method in 10 cases |
| Extensive resection and FRC in 3 cases | ||
| Fistula and plate exposure | 16 (26.7%) | Plate removal and wound care in 12 cases |
| Plate remove and FRC in 4 cases | ||
| Fistula and bone exposure | 7 (11.6%) | Debridement of necrotic bone in 5 cases |
| Bone debridement and FRC in 2 cases | ||
| Flap partial necrosis and infection | 9 (15.0%) | Conservative method in 7 cases |
| Extensive resection and FRC in 2 cases |
*Conservative method: debridement (remove of the necrotic soft tissues), dressing change everyday continued for about two weeks, and antibiotic prescription; *FRC: flap re-coverage.
Perioperative factors associated with PPI of ORNM in univariate analysis.
| Variable | Total | Infection | Non-infection | Odds ratio | 95% CI | P |
|---|---|---|---|---|---|---|
| Radiation Dose | ||||||
| <80 Gy | 184 (71.6) | 32 | 152 | 1 (reference) | ||
| | 73 (28.4) | 28 | 45 | 2.956 | 1.611–5.421 | <0.001 |
| Unilateral/bilateral ORNM | ||||||
| Unilateral | 237 (92.2) | 48 | 189 | 1 (reference) | ||
| Bilateral | 20 (7.8) | 12 | 8 | 5.906 | 2.286–15.257 | <0.001 |
| Skin fistula | ||||||
| None | 145 (56.4) | 24 | 121 | 1 (reference) | ||
| Yes | 112 (43.6) | 36 | 76 | 2.388 | 1.323–4.312 | 0.003 |
| Orocutaneous fistula | ||||||
| None | 165 (64.2) | 31 | 134 | 1 (reference) | ||
| Yes | 92 (35.8) | 29 | 63 | 1.990 | 1.105–3.583 | 0.021 |
| Pyorrhea | ||||||
| None | 135 (52.5) | 23 | 112 | 1 (reference) | ||
| Yes | 122 (47.5) | 37 | 85 | 2.120 | 1.173–3.831 | 0.012 |
| Implant utilization | ||||||
| None | 151 (58.8) | 26 | 125 | 1 (reference) | ||
| Yes | 106 (41.2) | 34 | 72 | 2.270 | 1.262–4.084 | 0.006 |
Logistic regression analysis of significant factors detected in univariate analysis.
| Viable | Exp (B) | 95% CI | P value | Points contributed |
|---|---|---|---|---|
| Radiation Dose | ||||
| <80 Gy | 1 (reference) | 0 | ||
| | 2.044 | 1.050–3.979 | 0.035 | 4 |
| Unilateral/bilateral ORNM | ||||
| Unilateral | 1 (reference) | 0 | ||
| Bilateral | 4.120 | 1.501–11.307 | 0.006 | 8 |
| Skin fistula | ||||
| None | 1 (reference) | 0 | ||
| Yes | 3.078 | 1.050–9.023 | 0.040 | 6 |
| Orocutaneous fistula | ||||
| None | 1 (reference) | — | ||
| Yes | 0.477 | 0.150–1.520 | 0.211 | — |
| Pyorrhea | ||||
| None | 1 (reference) | — | ||
| Yes | 1.666 | 0.757–3.665 | 0.205 | — |
| Implant utilization | ||||
| None | 1 (reference) | 0 | ||
| Yes | 2.115 | 1.125–3.976 | 0.020 | 4 |
Correlation of risk-stratification score with PPI.
| Group | Score | Total | Infection | No-infection | Single trend test p-value | Odds ratio | 95% CI |
|---|---|---|---|---|---|---|---|
| 1 | 0–6 | 170 (66.1) | 25 | 145 | — | 1 (reference) | — |
| 2 | 7–13 | 57 (22.2) | 18 | 39 | 0.006 (VS group1) | 2.677 | 1.327–5.399 |
| 3 | 14–22 | 30 (11.7) | 17 | 13 | 0.021 (VS gourp2) | 2.833 | 1.137–7.059 |
| <0.001 (VS group1) | 7.585 | 3.282–17.527 |
*VS: versus.
Figure 5Nomogram model for predicting the risk of postoperative infection. Every patient was assigned a total point value and corresponding hazard risk can be calculated in the axis of risk.
Figure 6Discrimination capability of nomogram model. Receiver operating characteristic (ROC) curve showed an area under curve (AUC) of 0.708.
Figure 7The calibration curve revealed adequate fit of the nomogram model in predicting the risk of PPI.